Effects of levosimendan in patients with acute heart failure and cardiorenal syndrome

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Cardiorenal syndrome (CRS) is common in patients with acute heart failure (AHF) and is associated with poor prognosis. Levosimendan (LVS) is an inodilator used in AHF and has beneficial effects on renal function (RF). However, it...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur Heart J Acute Cardiovasc Care
Hlavní autoři: Ribeiro Da Silva, M, Santos Silva, G, Caeiro, D, Passos Silva, M, Guerreiro, C, Teixeira, P, Ribeiro Queiros, P, Brandao, M, Ferreira, D, Sousa, O, Dias, A, Rodrigues, A, Braga, P
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
16.4.1 - Pharmacotherapy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264012/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.028
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky